Statewide Molecular Epidemiology of Mycobacterium tuberculosis Transmission in a Moderate- to Low-Incidence State: Are Contact Investigations Enough? by Cronin, Wendy A. et al.
Emerging Infectious Diseases  •  Vol. 8, No. 11, November 2002 1271
TUBERCULOSIS GENOTYPING NETWORK
Molecular Epidemiology 
of Tuberculosis in a Low- 
to Moderate-Incidence 
State: Are Contact 
Investigations Enough?
Wendy A. Cronin,* Jonathan E. Golub,* Monica J. Lathan,† Leonard N. Mukasa,* 
Nancy Hooper,* Jafar H. Razeq,* Nancy G. Baruch,* Donna Mulcahy,‡ 
William H. Benjamin,§ Laurence S. Magder,¶ G. Thomas Strickland,¶ 
and William R. Bishai# 
To assess the circumstances of recent transmission of tuberculosis (TB) (progression to active disease <2
years after infection), we obtained DNA fingerprints for 1,172 (99%) of 1,179 Mycobacterium tuberculosis
isolates collected from Maryland TB patients from 1996 to 2000. We also reviewed medical records and
interviewed patients with genetically matching M. tuberculosis strains to identify epidemiologic links (clus-
ter investigation). Traditional settings  for transmission were defined as households or close relatives and
friends; all other settings were considered nontraditional. Of 436 clustered patients, 115 had recently
acquired TB. Cluster investigations were significantly more likely than contact investigations to identify
patients who recently acquired TB in nontraditional settings (33/42 vs. 23/72, respectively; p<0.001).
Transmission from a foreign-born person to a U.S.-born person was rare and occurred mainly in public set-
tings. The time from symptom onset to diagnosis was twice as long for transmitters as for nontransmitters
(16.8 vs. 8.5 weeks, respectively; p<0.01). Molecular epidemiologic studies showed that reducing diagnos-
tic delays can prevent TB transmission in nontraditional settings, which elude contact investigations. 
 lthough tuberculosis (TB) remains a major public health
threat worldwide (1), its declining incidence in the
United States has led health policy makers to develop plans for
disease elimination (less than one patient per million) by 2010
(2). Although targeted screening and treatment of latent TB
infection has been recommended for groups at high risk (3),
learning more about recent TB transmission will help identify
specific program interventions that may prevent infection and
disease. 
Molecular epidemiology has been used to identify groups
most at risk for recent TB transmission in high-incidence
urban and rural areas of the United States (4–9), but little data
have been available from sites with a low-to-moderate disease
incidence. Maryland’s varied culture and geography provide a
microcosm for the study of TB transmission in the United
States. The population of 5.1 million resides in distinct areas:
urban (city of Baltimore), suburban (5 counties), and rural
coastal and mountainous areas (18 counties). Baltimore reports
high rates of homelessness, HIV infection, and illegal drug
use. Foreign immigration to suburban and some rural areas of
the state has increased by 53% in the past decade, causing
Maryland to rank third in the nation in rate of foreign popula-
tion growth (10). 
In spite of the presence of these groups at high risk of
acquiring TB, excellent treatment regimens utilizing directly
observed therapy (87% vs. 47% nationally) and four-drug ini-
tial therapy (89% vs. 77% nationally) resulted in a 15-year
decline in disease incidence (11). Since 1989, the state’s TB
incidence has remained lower than the national average (4.9/
100,000 vs. 5.6/100,000 population, respectively, in 2001)
(11), and Baltimore ranks 26th among 31 major U.S. cities for
TB incidence (Centers for Disease Control and Prevention
[CDC], unpub. data, 2000). 
As part of the CDC-supported National Tuberculosis
Genotyping and Surveillance Network, we used DNA finger-
printing of Mycobacterium tuberculosis isolates and patient
information to conduct a statewide epidemiologic study of cul-
ture-positive TB patients. We quantified the problem of recent
TB transmission in Maryland, characterized circumstances and
settings for transmission, and used our findings to review pro-
grammatic interventions.
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Methods
Collection of Isolates and DNA Fingerprinting
M. tuberculosis isolates from all patients with a positive
culture reported to the Maryland Department of Health and
Mental Hygiene (DHMH) between 1996 and 2000 were
retrieved from respective reporting laboratories. Restriction
fragment length polymorphism (RFLP) analysis of IS6110 was
performed with the standard method (12). Spoligotyping was
performed for all matching strains that had six or more IS6110
copies by using a commercially available kit, according to the
manufacturer’s instructions (Isogen Bioscience BV, Maarssen,
the Netherlands) (13). Patients with genetically related M.
tuberculosis strains were considered clustered. For high-copy
(more than six) IS6110 strains, patients whose isolate patterns
matched exactly, or differed by one band, were assigned a sin-
gle cluster designation (14,15). For low-copy (six or fewer)
strains, cluster designations were assigned to patients whose
isolates matched exactly by RFLP analysis and spoligotyping. 
Demographic and TB Risk Information
For all culture-positive patients with available DNA fin-
gerprints, we obtained routinely reported demographic and
risk factor information (HIV infection, homelessness, incar-
ceration, alcohol abuse and illegal drug use, long-term care
residence, and foreign birth) from the state case registry. These
data were used to compare patients by estimated time of TB
acquisition.
Cluster Investigation
After obtaining genotype results, we abstracted medical
records of the clustered patients to determine whether epide-
miologic links existed with other patients in the same cluster.
We obtained medical histories and information on workplaces,
schools, social settings, known or suspected TB exposures,
tuberculin skin test results, and contact investigation records.
Locatable clustered patients who had no documented links
were interviewed to determine whether an existing relation-
ship had eluded the local health department staff who con-
ducted the contact investigations. We assigned epidemiologic
links to patients who were named by another TB patient or
were in the same place at the same time as another TB patient,
even when they did not name each other. When the date and
location of specimen collection and laboratory processing sug-
gested that a clustered patient’s specimen was falsely positive,
a pulmonologist reviewed medical records and chest radio-
graphs to determine whether clinical TB was likely (16,17).
Researchers used standardized forms to abstract records and
interview patients. The study was approved by DHMH and
CDC’s institutional review boards, and patients signed
informed consent forms before interviews.
Estimated Time of TB Acquisition
Patients with “recent TB” were defined as those who had
become infected within 2 years of  disease diagnosis by an
identified source patient with a matching fingerprint and
whose transmission setting was known. Symptom onset had to
occur at least 1 month after the onset date of the source’s
symptoms. The onset date was obtained from the patient’s
report or conservatively estimated to be 14 days before the
date the first positive specimen was collected or the date that
treatment was begun, whichever came first. Patients with
“probable recent TB” were defined as all clustered patients
who had no known transmission from source patients or evi-
dence of past infection, e.g., no history of previous disease or
documented positive results of a tuberculin skin test. 
The category of “reactivated TB” from latent TB infection
was assigned to clustered patients with documented past infec-
tion or disease and no identified source case, and to all patients
with unique M. tuberculosis strain patterns (4,5). Although
disease acquisition from a patient residing in another state or
from exogenous reinfection could not be completely excluded,
we assumed that these events were rare (18,19). 
Traditional and Nontraditional Transmission Settings
Traditional settings for transmission were defined as those
settings routinely investigated during contact investigations,
e.g., households and transmission between close friends and
relatives in any location. All other settings where transmission
occurred were considered nontraditional. 
Time from Symptom Onset to Treatment Initiation
Using only clustered patients as a convenience sample, we
compared the times from reported symptom onset to treatment
initiation between transmitters (persons who were the source
of infection for a patient with recent TB) and nontransmitters
(persons who were never identified as a source for another
patient). The possibility of transmission was evaluated through
September 2002, 21 months after the last patient in the study
was reported. 
Exclusions
Patients with M. bovis infection were excluded. Those with
a DNA-confirmed TB relapse (disease occurring >12 months
after treatment was completed, due to an identical M. tubercu-
losis strain) (20) were counted only for the first disease epi-
sode. All patients whose time of TB acquisition was
undetermined were excluded, including those whose cultures
were negative for M. tuberculosis and the first patient in a
cluster if no source patient was identified (5). Although the
infections of patients >5 years of age were recent by defini-
tion, children whose cultures were negative were not included
in this molecular epidemiologic study, and those results are
described elsewhere (21). Finally, because spoligotyping
poorly differentiates clustered M. tuberculosis strains with low
copy IS6110 in population-based studies (22), we could not
confidently determine when TB was acquired by patients who
had low-copy IS6110 strains and no known source acquired
TB. These patients were excluded from our comparison
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Analysis
Chi-square tests were conducted for all categorical analy-
ses; Fisher exact test was used when expected cell values were
<5. Student t test was used for continuous variables. 
Results
Culture-Positive TB Patients
Of 1,554 TB patients reported from 1996 through 2000, a
total of 1,198 (77%) had positive cultures. The cluster investiga-
tions revealed that specimens from 11 patients were false posi-
tive, and these patients were deleted from our state TB registry.
Five patients with non–BCG M. bovis were excluded, and three
patients who had DNA-confirmed disease relapse were counted
once. No instances of exogenous reinfection from a different M.
tuberculosis strain were identified. DNA fingerprints were
available for 1,172 (> 99%) of 1,179 patient isolates. 
Of the 1,172 patient isolates, 436 (37%) were grouped in
111 clusters (median patients per cluster 2; mean 3; range 2–
19). Eighty-eight (79%) clusters included persons who resided
in one or two adjacent jurisdictions within the state. Overall,
155 (36%) clustered patients were epidemiologically linked to
another patient in the cluster; among 336 with high-copy
IS6110 strains, 148 (44%) were linked. 
Time of TB Acquisition
The time of TB acquisition could not be determined for 42
patients who were the first symptomatic patient in their respec-
tive cluster and had no known source patient, and 145 patients
who had low-copy IS6110 strains and no known source
patients (Table 1). These 187 were excluded from our compar-
ison between patients by time of acquisition. However, 29 of
the 187 patients were the source for another patient and were
included in our analyses of paired source and secondary
patients, and of transmitters and nontransmitters.
Of the 985 patients with a known time of infection and sub-
sequent disease, 115 (12%) had recent TB and an additional 82
(8%) had probable recent TB. Fourteen (17%) of these 82 had
documented previous negative skin tests. Our extensive case
review showed no sources for 56 clustered patients who had
documented histories of past infection or disease. We presumed
that these 56 patients plus the 732 patients with unique M.
tuberculosis strains had reactivated disease (n=788). 
Patients with recent TB were significantly more likely than
patients with probable recent TB to be young and U.S. born,
but the proportions of patients with urban residence, HIV infec-
tion, illegal drug use, and homelessness were similar for both
groups (Table 2). Among the 25 patients with probable recent
TB who were >64 years old, 4 were foreign-born, 10 were
users of illegal drugs or alcohol, and 2 were homeless. Patients
with recent TB were more likely than those with reactivated
disease to be urban residents, young, black, U.S.-born, home-
less, HIV-infected, and abusers of alcohol or illegal drugs.
Risk Factors among Paired 
Source and Secondary Patients
Of the 115 patients with recent TB, 114 had 69 sources
with available risk information. The mean number of second-
ary patients per source was 1.6 (median 1; range 1–12). Six
(5%) of the 114 secondary patients acquired a resistant M.
tuberculosis strain (primary resistance) from their source; 2 of
these 6 were foreign-born. Five patient-strains were resistant
to streptomycin and one was resistant to isoniazid. Risks, par-
ticularly illegal drug use, were frequently the same for respec-
tive source and secondary patients. Risks were identical (e.g.,
both source and secondary patients were injection drug users,
homeless, HIV-infected) for 47 (72%) of 65 patient pairs aged
15–44 years. We found no transmission from U.S.-born per-
sons to foreign-born persons. Other than birth in a country
with a high disease incidence, only 2 (11%) of 18 foreign-born
sources had risks compared with 46 (90%) of 51 U.S.-born
sources (p<0.001). Foreign-born persons were the sources for
all 10 foreign-born secondary patients and eight U.S.-born sec-
ondary patients. Among the latter, two were young children
who acquired infection from a relative. Nonhousehold trans-
mission from foreign-born persons to the remaining six U.S.-
born persons occurred in a school, a hospital (22), two
churches, and two workplaces. Five of these U.S.-born
patients were immunocompetent, and their only risk for TB
was exposure to the infectious source patient.  
Identification of Recent Transmission 
before and after Genotyping
Source cases and settings of transmission were identified
for all instances of recent transmission except one, a 3-year-
old child (n=114). Fifty-six (49%) patients with recent TB
Table 1. Estimated time of infection and disease acquisition among Mycobacterium tuberculosis culture-positive patients by DNA cluster statusa
DNA cluster status of patients’ isolates
No. patients with 
recent TB
No. patients with 
probable recent TB
No. patients with 
reactivated TB
No. patients with unknown 
time of TB acquisition Totals
Clustered strains with >6 IS6110 copies 89 82 56b 42c 269
Clustered strains with <6 IS6110 copies 22   0 0 145 167
Nonclustered strains  4d 0 732 0 736
Total 115 82 788 187 1,172
aTB, tuberculosis.
bHistory of previous positive tuberculin skin test or extensive past exposure to a patient.
cFirst patient in a cluster by estimated date of symptom onset and no identified source patient. 
dKnown link to another patient outside the study area or timeframe whose isolate had the same DNA fingerprint.TUBERCULOSIS GENOTYPING NETWORK
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acquired their infection and disease in nontraditional settings
(Table 3). Less than two-thirds of the recent patients’ epidemi-
ologic links to their source patients were identified by routine
contact investigations before genotyping. Patients identified
by contact investigations were significantly less likely to have
acquired TB in nontraditional settings than those identified by
cluster investigations (23/72 vs. 33/42, respectively; p<0.001). 
The importance of nontraditional settings among persons
at high risk was influenced in part by large outbreaks (three or
more secondary patients) (23–29). Nine of these began in non-
traditional settings and ultimately expanded to traditional set-
tings, and cluster investigation identified additional outbreak-
related infections in patients who had not been identified
through routine contact investigations (25–27).
TB acquisition in nontraditional settings was associated
with age >14 years (p=0.033, compared to younger patients
aged 0 to 14 years), U.S. birth (p=0.012, compared to foreign
birth), and illegal drug use (p<0.001, compared to nonusers).
Table 2. Selected characteristics of culture-positive patients with comparison between categories
Characteristic
No. patients with recent 
TB (%) (n=115)
No. patients with probable 
recent TB (%) (n=82)
No. patients with reactivated 
TB (%) (n=788)
p value p value
    Group A     Group B    Group C A vs. B A vs. C
Residence
  Baltimore City  57 (50.0) 38 (46.3) 157 (19.9) 0.66 <0.001
  Other state jurisdictions 58 (50.0) 44 (53.7) 631 (80.1)
Age group (yrs)
   0–14a 6 (5.2) 3 (3.7) 5 (0.6) <0.001 <0.001
   15–24 21 (18.3) 7 (8.5) 86 (10.9)
   25–44 46 (40.0) 27 (32.9) 275 (34.9)
   45–64 33 (28.7) 20 (24.3) 178 (22.6)
   >65  9 (7.8) 25 (30.4) 244 (31.0)
Race/ethnicity
   White, non-Hispanic 20 (17.4) 17  (20.7) 162 (20.6) 0.03 <0.001
   Black, non-Hispanic 89 (77.4) 51  (62.2) 341 (43.3)
   Hispanic 1 (0.9) 5   (6.1) 84 (10.7)
   Asian 5 (4.3) 9 (11.0) 200 (25.4)
   Native American  0  0 1 (0.1)
Country of birth
   United States 105 (91.3) 66 (80.5) 360 (45.7) 0.03 <0.001
   Other 10 (8.7) 16 (19.5) 428 (54.3)
Long-term care resident
   Yes  7 (6.1) 5 (3.3) 25 (3.2) 1.00 0.11
   No 108 (93.9) 77 (96.7) 763 (96.8)
Homeless
   Yes 18 (15.7) 8 (9.8) 23 (2.9) 0.22 <0.001
   No 97 (84.3) 74 (90.2) 765 (97.1)
Prison resident
   Yes  13 (11.3) 10 (13.1) 21 (2.7) 0.85 <0.001
   No 102 (88.7) 72 (86.9) 767 (97.3)
Uses illegal drugs or abuses alcohol
   Yes  53 (46.0) 30  (36.6) 76 (9.6) 0.18 <0.001
   No 62 (54.0) 58  (63.4) 712 (90.4)
HIV-infected
   Yes 28 (24.3) 19 (23.2) 75 (9.5) 0.85  <0.001
   No 87 (75.7) 63 (76.8) 713 (90.5)
aIncludes one child <6 years old without a known source patient; the case was classified as recent based on age.Emerging Infectious Diseases  •  Vol. 8, No. 11, November 2002 1275
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At least 5 of 15 patients who acquired TB in public settings,
i.e., churches, hospitals, a school, and a store, had only brief or
distant (casual) exposure to a highly infectious person (24,28).
Nine (60%) of the 15 had no apparent TB risk factor except
exposure to their source patient. 
TB transmission occurred in households for all 10 foreign-
born persons with recent TB, and the sources for all but one
foreign-born patient were found by contact investigations
(Table 4). Cluster investigations were significantly more likely
than contact investigations to identify source cases for patients
who were homeless, abusers of alcohol, or both. Recent
patients with other common TB risk factors, i.e., HIV infec-
tion, illegal drug use, incarceration, and long-term care resi-
dence, were equally likely to have epidemiologic links
identified by cluster or contact investigations.
Time from Symptom Onset to Treatment Initiation
The estimated time of symptom onset was available for 69
transmitters and 99 nontransmitters. TB transmitters were sig-
nificantly more likely than nontransmitters to have pulmonary
disease (68/69 vs. 73/99; p<0.001). Among patients with pul-
monary disease, transmitters were more likely than nontrans-
mitters to have lung cavitation (40/68 vs. 14/73; p<0.001) and
sputum smears positive for acid-fast bacilli (64/68 vs. 59/73;
p=0.034). Among transmitters, the mean time from symptom
onset to treatment initiation was 16.8 weeks compared with
8.5 weeks among nontransmitters (median 11 vs. 6 weeks,
respectively; p=0.008). Transmitters also were more likely
than nontransmitters to have at least one risk factor for TB,
e.g., homelessness, HIV infection, alcohol abuse, or illegal
drug use, residence in a long-term care facility, incarceration,
foreign birth (60/69 vs. 38/99, respectively; p<0.001). 
Discussion
Our 5-year molecular epidemiologic study featured a com-
plete sampling of patients’ isolates from the entire state
(30,31) and a multifaceted study site. We also compared our
patient groups by time of disease acquisition to more clearly
define the relationship between clustering and recent transmis-
sion in the state. Even though Maryland has low-to-moderate
TB incidence, results from our comparison between groups
with recent, probable recent, and reactivated TB were similar
to those from studies conducted among clustered and nonclus-
tered patients in high incidence urban and rural areas. Recent
and probable recent TB acquisition were associated with
patients who were young, homeless, users of alcohol and ille-
gal drugs, HIV-infected, and incarcerated. These findings fur-
ther support the assumption that clustering is a reasonable,
though not exact, surrogate for recent transmission (4–9). 
The importance of clustered patients who do not have
identifiable links has remained unclear (32). By assuming that
clustered patients without links and with histories of old infec-
tions or previous TB had reactivated disease, we attempted to
be more specific in identifying those for whom recent TB was
plausible. Our patients with probable recent TB were older and
more likely to be foreign-born than were patients with recent
TB. Half of the elderly patients had other high-risk factors that
made exposure and recent infection likely. Among the foreign-
born, acquisition of endemic strains in their countries of origin
could account for some clustering (33). However, patients with
probable recent TB had risk factors similar to those of patients
with known recent TB. The most likely explanation for most
clustered patients in this group is that existing epidemiologic
links remained unidentified by contact or cluster investiga-
tions, and that some had casual exposures to their source
patients in unidentified settings. 
Patients with reactivated disease were rarely misclassified.
Among clustered patients with histories of old infection, dis-
ease, or both, our extensive review revealed no source
patients. In addition, as of July 2002, we found no instances of
exogenous reinfection by a different M. tuberculosis strain
even among HIV-infected patients. Because genotyping was
Table 3. Identified transmission settings for 114 patients with recently acquired tuberculosis (TB)
Settings
Total patients with known 
settings (%)
Setting identified by routine contact 
investigation (%)
Setting identified by DNA cluster 
investigation (%)
Traditional
  Household
  Close relative
  Close friend
 Nontraditional  
  Hospital (24,28)
  Other workplace (25)
  Social club (26)
  Homeless shelter
  Bar
  Prison/jail (26)
  Store (27)
  Church
  Nursing home
  School 
  Ship 
  Mortuary (29)
Total
  
28 (24.6)
13 (11.4)
17 (14.9)
10 (8.8)
6 (5.3)
11 (9.6)
5 (4.4)
10 (8.8)
5 (4.4)
2 (1.8)
2  (1.8)
2  (1.8)
1 (0.9)
1 (0.9)
1 (0.9)
114 (100.0)
25 (34.7)
13 (18.1)
11 (22.2)
5 (6.9)
6 (8.3)
7 (9.7)
0
1 (1.4)
3 (4.2)
0
0
0
0
1 (1.8)
0 (1.4)
72 (100.0)
3 (7.1)
0
6 (14.3)
 5 (11.9)
0
4 (9.5)
5 (11.9)
9 (21.4)
2 (4.8)
2 (4.8)
2 (4.8)
2 4.8)
1 (2.4)
0 (2.4)
1 (2.4)
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not conducted in adjoining states, we could not eliminate the
possibility of cross-jurisdictional transmission to patients who
had unique M. tuberculosis strains. Recent TB was transmitted
from three patients in Washington, D.C., to four Maryland res-
idents (DHMH, unpub. data, 2001); disease incidence is
greater in Washington, D.C., than in Maryland (14.9 vs. 5.3
per 100,000 population, respectively, in 2000) (34). Only 13%
of TB patients resided in rural counties that form most of
Maryland’s border. With low incidence in adjacent Delaware,
Pennsylvania, Virginia, and West Virginia (3.6, 3.1, 4.1, and
1.8 patients per 100,000 population, respectively, in 2000)
(34), transmission between states was probably minimal. 
Transmission to and from Foreign-Born Persons
Most recent transmission occurred between U.S.-born per-
sons who had at least one common urban risk factor such as
HIV infection or illegal drug use. In contrast, transmission
between foreign-born persons occurred exclusively in house-
holds among persons who had no other risk except their arrival
from a high-incidence country of origin or close exposure to
their source patient. We found no instances of transmission
between U.S.-born and foreign-born persons. These results
differed from other studies, which reported that foreign-born
patients who acquired TB from U.S.-born sources shared risks
such as homelessness, HIV infection, and illegal drug use with
those source patients (35,36). In the past decade, few immi-
grants and refugees settled in the city of Baltimore where
urban risks are common (10). From 1996 through 2000, only
36 (9%) of 423 Baltimore patients were foreign-born com-
pared with 642 (57%) of 1,120 patients in other Maryland
areas (DHMH, unpub. data, 2001). In general, foreign migra-
tion to Maryland is relatively new (10), and we may observe
more shared risks among U.S.- and foreign-born patients as
time of residence increases. This study is unique in reporting
that infectious foreign-born sources to U.S.-born persons pri-
marily transmitted the disease to persons whose only risk was
exposure in their workplace or a public setting, such as a
church or school. 
Table 4. Comparison of selected risk-group characteristics of 114 recent tuberculosis (TB) patients by method of source patient identification
Characteristic 
Total recent TB patients
(n=114) (%)
Source patient identified 
by routine contact 
investigation (n=72) (%)
Source patient identified by 
cluster investigation
(n=42) (%) p value
Residence
  Baltimore city  56 (49.0) 33 (45.8) 23 (54.8) 0.38
   Other state jurisdictions 58 (51.0) 39 (54.2) 19 (45.2)
Country of birth
  United States 104 (91.3) 63 (87.5) 41 (97.6) 0.07
  Other 10 (8.7) 9 (12.5) 1 (2.4)
Long-term care resident
  Yes 7 (6.1) 3 (4.2) 4 (9.5) 0.25
  No 107 (93.9) 69 (95.8) 38 (90.5)
Homeless
  Yes 18 (15.8) 6 (8.3) 12 (28.6) 0.004
  No 96 (84.2) 66 (91.7) 30 (71.4)
Prison resident 
  Yes  13 (11.4) 8 (11.1) 5 (11.9) 0.86
  No 101 (88.6) 64 (88.9) 37 (88.1)
Abuses alcohol
  Yes  40 (35.0) 19 (26.4) 21 (50.0) 0.01
  No 74 (65.0) 53 (73.6) 21 (50.0)
Uses injection drugs 
  Yes  17 (14.9) 11 (15.3) 6 (14.3) 0.89
   No 97 (85.1) 61 (84.7) 36 (85.7)
Uses noninjection drugs 
  Yes  35 (30.7) 23 (31.9) 12 (28.6) 0.71
  No 79 (69.3) 49 (68.1) 30 (71.4)
HIV-infected
  Yes 28 (24.6) 16 (22.2) 12 (28.6) 0.45
  No 86 (75.4) 56 (77.8) 30 (71.4)Emerging Infectious Diseases  •  Vol. 8, No. 11, November 2002 1277
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Identification of Recent Transmission 
before and after Genotyping
In spite of a recommended concentric circle approach for
routine contact investigations that includes leisure and social
locations (37), we found that investigations usually had been
conducted in the homes of patients and rarely extended beyond
friends and relatives. Nonetheless, the high proportion of
recent patients who acquired TB in these traditional settings
clearly represented numerous missed opportunities for disease
prevention. Although recent TB was diagnosed among some
patients during the initial contact investigation, not all identi-
fied contacts had received postexposure tuberculin skin tests
or treatment for latent infection (25). More timely and com-
plete contact investigations could reduce the risk for transmis-
sion in traditional settings. 
Perhaps more importantly, almost half of recent TB cases
were acquired in nontraditional settings. Many of these
patients were from marginalized groups at high risk, who may
have been reluctant or unable to provide names of their associ-
ates to contact investigators. However, cluster and contact
investigations were equally effective in identifying sources for
patients with recent TB who were illegal drug users, incarcer-
ated, and HIV-infected, and more aggressive contact investiga-
tions would probably not substantially improve patient
reporting. Instead, our data suggest that the setting, and not the
risk group, eludes routine contact investigators. 
In addition, TB genotyping and cluster investigations indi-
cated unsuspected transmission to immunocompetent persons
in public locations such as churches, hospitals, and stores. In
these instances, the possibility of casual transmission must be
considered. Casual transmission was likely in the store out-
break (28) and conceivably could account for some patients
with probable recent TB for whom epidemiologic links were
not found. Rarely reported, casual transmission occurs when
the bacterial load of the source patient is high, the infecting
organism has inherent increased virulence, or the environment
is enclosed (28,38). Without creative intervention, the propor-
tional contribution of casual transmission will increase sub-
stantially as the disease incidence decreases.
Delayed Diagnosis Among Transmitters
The mean time between reported symptom onset and initi-
ation of treatment among transmitters was twice that identified
for nontransmitters. Whether treatment delays are due to
patients who delay in seeking care or to providers who do not
include TB in the differential diagnosis, treatment delays pro-
vide ample time for pulmonary TB patients to develop smear-
positive disease and cavitation (39–41). Our findings led to a
study to determine what time period defines a diagnostic delay
and to identify related client and provider factors that will
guide future program interventions (42). 
Conclusion
Even with excellent treatment indices, one sixth of Mary-
land’s patients with positive cultures had recent or probable
recent disease. The new guidelines for targeted testing and
treatment for latent TB infection (3) will require time and sub-
stantial resources for successful implementation, and more
practical and timely interventions are needed to minimize TB
transmission. In the figure, we summarize the program activi-
ties that are needed to reduce transmission from infectious TB
patients in the various scenarios described in this article. Pro-
gram implications include the need for improved contact
investigations tailored more carefully to each patient’s particu-
lar situation, with increased emphasis on activities and patient
contacts outside the immediate household. However, contact
investigations cannot fully address the problem of transmis-
sion in nontraditional settings. Decreasing diagnostic delays
can potentially eliminate large point source clusters and sub-
stantially reduce transmission in both traditional and nontradi-
tional settings. This method may be the only way to prevent
casual transmission. Additional molecular epidemiologic
investigations are needed to determine the importance of
casual transmission, clarify the importance of clustered
patients without links to other patients, and evaluate the long-
term effectiveness of new program interventions.
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